The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry

Subscribe and Listen

An audio version of “The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry,” a new commentary by CSIS's Sujai Shivakumar, Charles Wessner, and Julie Heng. This audio was generated with text-to-speech by Eleven Labs.

Charles Wessner

Charles Wessner

Senior Adviser (Non-resident), Renewing American Innovation
Julie Heng

Julie Heng

Research Associate, Renewing American Innovation

Programs & Projects